Drooid Logo
Back to story perspectives

Full Breakdown

Brain-Computer Interface Restores Voice for ALS Patient

6/18/2026, 2:15:03 AM

Breakthrough BCI Enables Real-World Speech

Casey Harrell, a 47-year-old with advanced ALS, received a surgical implant of electrode arrays in the speech-motor cortex in early 2023. The arrays feed a brain-computer interface that converts neural firing into text, which a speech synthesizer renders in a voice modeled on Harrell’s pre-ALS tone. After two years, Harrell operates the system independently from a mobile cart, enabling real-time conversation without researcher assistance.

From Lab Proof-of-Concept to Home Use

Brain-computer interfaces have previously been limited to tightly controlled labs. The BrainGate 2 pilot trial, launched by UC Davis with Brown University and Mass General Brigham, tests safety and feasibility for people with severe speech loss, marking the first unsupervised home use.

Performance Data

Harrell has logged over 3,800 hours of neural recording across 400 days, the largest single-subject dataset with single-neuron resolution. The decoder averages 56 words per minute, has generated more than 183,000 sentences (?2 million words), and shows accuracy reported between 92 percent and over 99 percent. A user-activated privacy mode can halt data capture.

Daily Impact and Employment

The interface lets Harrell send emails, browse the internet and keep a full-time job without assistance. A synthetic voice, tuned to his pre-ALS timbre, lets his wife hear a familiar sound and his daughter recall his former speech. Harrell calls the experience a “life full of dynamic action” that restores his natural communication style.

Official Statements

UC Davis investigators stress that BrainGate 2 assesses safety and functional feasibility for severe paralysis. They say Harrell’s extensive recordings will sharpen decoding algorithms and deepen insight into neural speech, viewing the trial as a threshold that could speed future therapies.

Conflicting Reports & Gaps

Sources differ on accuracy, citing 92 percent versus over 99 percent correct transcription. Long-term implant durability and broader applicability across diverse ALS populations remain unaddressed.

Verbatim Quotes

  • “It is very sweet to have the ability to look at my wife’s eyes when she hears my voice and conjures up a sweet memory,” — Casey Harrell
  • “For years, BCIs have been proof-of-concept devices that lived in highly controlled research labs,” — Dr. David Brandman
  • “This work shows that we may have crossed a threshold by empowering a person with paralysis to speak on his own terms.” — Dr. David Brandman
  • “Casey can use the system to communicate his own thoughts, not only while we're there in a controlled environment, but whenever he wants," says Nicholas Card, postdoctoral scholar, UC Davis Neuroprosthetics Lab "Sometimes, he would do that over 12 straight hours.” — Nicholas Card

Future Directions

The BrainGate 2 trial will enroll 26 additional participants, using Harrell’s dataset to improve decoding fidelity and expand vocabulary coverage. Results published in *Nature Medicine* signal a path toward broader clinical deployment.